AdvisorShares Vice ETF (ACT) financial statements (2020 and earlier)

Company profile

Business Address MORRIS CORPORATE CENTER III
PARSIPPANY, NJ 07054
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments328
Cash and cash equivalents319
Short-term investments9
Receivables1,303
Inventory, net of allowances, customer advances and progress billings1,543
Inventory1,543
Prepaid expense and other current assets404
Other undisclosed current assets302
Total current assets:3,880
Noncurrent Assets
Property, plant and equipment1,480
Long-term investments and receivables10
Long-term investments10
Intangible assets, net (including goodwill)8,592
Goodwill4,762
Intangible assets, net (excluding goodwill)3,830
Prepaid expense and other noncurrent assets81
Other undisclosed noncurrent assets62
Total noncurrent assets:10,224
TOTAL ASSETS:14,104
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,429
Employee-related liabilities260
Taxes payable68
Other undisclosed accounts payable and accrued liabilities2,100
Debt176
Deferred revenue and credits32
Deferred tax liabilities5
Other undisclosed current liabilities68
Total current liabilities:2,711
Noncurrent Liabilities
Long-term debt and lease obligation6,257
Long-term debt, excluding current maturities6,257
Liabilities, other than long-term debt1,237
Deferred revenue and credits11
Pension and other postretirement defined benefit plans, liabilities20
Accrued income taxes8
Deferred tax liabilities, net1,035
Other liabilities163
Other undisclosed noncurrent liabilities42
Total noncurrent liabilities:7,537
Total liabilities:10,247
Stockholders' equity
Stockholders' equity attributable to parent3,834
Common stock0
Treasury stock, value(343)
Additional paid in capital1,957
Accumulated other comprehensive income37
Retained earnings2,183
Stockholders' equity attributable to noncontrolling interest23
Total stockholders' equity:3,856
TOTAL LIABILITIES AND EQUITY:14,104

Income statement (P&L) ($ in millions)

12/31/2012
Revenues5,915
Revenue, net5,915
Cost of revenue(3,997)
Cost of goods and services sold(3,493)
Gross profit:1,918
Operating expenses(1,597)
Operating income:321
Nonoperating expense(76)
Other nonoperating income39
Interest and debt expense(117)
Income from continuing operations before equity method investments, income taxes:128
Income from equity method investments1
Other undisclosed income from continuing operations before income taxes115
Income from continuing operations before income taxes:245
Income tax expense(147)
Net income:98
Net loss attributable to noncontrolling interest(1)
Net income available to common stockholders, diluted:97

Comprehensive Income ($ in millions)

12/31/2012
Net income:98
Other comprehensive income113
Comprehensive income:212
Comprehensive income, net of tax, attributable to noncontrolling interest1
Other undisclosed comprehensive loss, net of tax, attributable to parent(2)
Comprehensive income, net of tax, attributable to parent:211

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: